Global perspective. Clear attribution. Updated throughout the day.
Live desk Concise briefs from trusted publishers · Always follow the source for the full report
Markets
GBP/USD 1.3392 FrankfurterEUR/USD 1.1485 FrankfurterUSD/NGN 1,330.11 FrankfurterUSD/JPY 157.29 FrankfurterGold $4,348.80/oz Gold APISilver $66.25/oz Gold API
Breaking
Government rules out tariff rise as power sector strains persist Punch NigeriaTwo killed as bandits attack Sokoto community and take livestock Punch NigeriaECOWAS court president urges reforms as regional tribunal marks 25 years Punch NigeriaPunch Nigeria recap highlights Tinubu vacation extension and Dangote IPO plan Punch NigeriaFive Premier League hat-trick scorers suffered defeat in unusual matches Punch NigeriaRuto says Kenya ready to begin Dangote refinery project in Lamu Punch NigeriaUnidentified woman’s decomposing body found in Rivers stream Punch NigeriaDutch company begins Rivers project to use flared gas for energy Punch NigeriaPlateau governor orders dusk-to-dawn curfew in three LGAs Punch NigeriaOffa Polytechnic restarts examinations after staff-management dispute Punch Nigeria
Scores
Aldosivi v Atlético Tucumán 1–0 Argentinian Primera Division · TheSportsDBBarracas Central v Independiente Rivadavia 22:00 UTC Argentinian Primera Division · TheSportsDBVélez Sarsfield v Tigre 3–2 Argentinian Primera Division · TheSportsDB
Science & Health

Karnataka seeks Pfizer standards to help identify fake medicines

Source: The Hindu · 21 Sep 2026, 19:20 UTC
Karnataka seeks Pfizer standards to help identify fake medicines
Image: The Hindu · original report

Karnataka’s health department has written to Pfizer headquarters seeking reference standards to help laboratories, doctors and pharmaceutical companies distinguish genuine medicines from counterfeit products, Health Minister U.T. Khader said, according to The Hindu.

Karnataka’s health department has written to Pfizer’s headquarters seeking reference standards for the company’s medicines, Health Minister U.T. Khader said, according to The Hindu. Khader said the standards would help laboratories, doctors and pharmaceutical companies differentiate between genuine and counterfeit drugs.

The request follows a fake-drug bust, according to the headline supplied with the report. The minister said access to the standards would make it easier for the relevant institutions to check whether products attributed to Pfizer were original. The available material does not specify which medicines are involved or identify the products seized in the bust.

It also does not give details of the department’s correspondence, Pfizer’s response, the location of the seizure or any action taken against people connected to the alleged counterfeit medicines.

About this report
This independently written report is based on information supplied by the named publisher. Vertrix News has not independently verified the source report.
View the original source at The Hindu →